首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于SOE-PCR的核酸疫苗pIRES2-MLAA34-HSP70的构建及免疫效果研究
引用本文:赵佳琪,王婉莹,范业宁,马春平,张东红,吕扬,赵臣.基于SOE-PCR的核酸疫苗pIRES2-MLAA34-HSP70的构建及免疫效果研究[J].重庆医学,2017,46(19).
作者姓名:赵佳琪  王婉莹  范业宁  马春平  张东红  吕扬  赵臣
作者单位:吉林医药学院检验学院,吉林吉林,132013
基金项目:吉林省科技厅自然科学基金资助项目,吉林省卫生和计划生育委员会项目,吉林省教育厅“十三五”科技项目,吉林省大学生创新创业课题,国家级大学生创新创业训练计划项目
摘    要:目的 构建pIRES2-MLAA34-HSP70重组质粒,并检测其免疫效果.方法 采用逆转录PCR(RT-PCR)的方法提取急性单核细胞白血病相关抗原基因MLAA-34和热休克蛋白(HSP) 70基因,设计特异性重叠引物,以重叠延伸PCR(SOE-PCR)技术扩增MLAA34-HSP70融合基因,构建核酸疫苗pIRES2-MLAA34-HSP70.将核酸疫苗免疫BALB/c小鼠,检测小鼠脾淋巴细胞对U937细胞的杀伤作用及小鼠脾细胞悬液中白细胞介素(IL)-2、IL-4和γ干扰素(IFN-γ)水平.结果 扩增出MLAA34-HSP70融合基因2 956 bp,成功构建了核酸疫苗pIRES2-MLAA34-HSP70,经鉴定与预期结果一致;脾淋巴细胞杀伤活性结果显示,核酸疫苗pIRES2-MLAA34-HSP70对U937细胞的杀伤效率明显高于其他实验组及对照组(P<0.01);核酸疫苗pIRES2-MLAA34-HSP70组细胞因子IL-2、IL-4和IFN-γ水平亦明显高于其他实验组及对照组(P<0.01).结论 成功构建了pIRES2-MLAA34-HSP70核酸疫苗,该核酸疫苗能诱发强烈的体液免疫,增强机体对肿瘤细胞的免疫应答,对MLAA34阳性细胞具有特异性杀伤作用.

关 键 词:疫苗  DNA  重叠延伸PCR  白血病  单核细胞  急性  MLAA-34  热休克蛋白质类70

Study on immune effect of DNA vaccine pIRES2-MLAA34-HSP70 constructed by SOE-PCR
Zhao Jiaqi,Wang Wanying,Fan Yening,Ma Chunping,Zhang Donghong,Lv Yang,Zhao Chen.Study on immune effect of DNA vaccine pIRES2-MLAA34-HSP70 constructed by SOE-PCR[J].Chongqing Medical Journal,2017,46(19).
Authors:Zhao Jiaqi  Wang Wanying  Fan Yening  Ma Chunping  Zhang Donghong  Lv Yang  Zhao Chen
Abstract:Objective To construct the DNA vaccine pIRES2-MLAA34-HSP70,and to detect its immune effect.Methods The acute monocytic leukemia associated antigen gene MLAA-34 and heat-shock protein (HSP)70 gene were extracted by using RT-PCR.The specific overlapping primer was designed,and the fusion gene MLAA34-HSP70 was amplified by using SOE-PCR technique.Then the DNA vaccine pIRES2-MLAA34-HSP70 was constructed,and BALB/c mice were immunized with this DNA vaccine.The splenic lymphocyte killing activity was detected by using MTT,levels of IL-2,IL-4 and IFN-γ were also detected by using ELISA.Results The MLAA34-HSP70 gene (2 956 bp) and the DNA vaccine pIRES2-MLAA34-HSP70 was amplified and constructed successfully.The killing efficiency of DNA vaccine pIRES2-MLAA34-HSP70 in U937 cells was significantly higher than that in other experimental groups and control group (P<0.01),and levels of IL-4,IL-2 and IFN-γin DNA vaccine pIRES2-MLAA34-HSP70 group were significantly higher than those in the other experimental groups and control group (P<0.01).Conclnsion The DNA vaccine pIRES2-MLAA34-HSP70 is constructed successfully.It is shown that the DNA vaccine induces strong humoral immunity,which could enhance immune responses to tumor cells and specificlly kill MLAA34 positive cells.
Keywords:vaccines  DNA  gene splicing by overlap extension PCR  leukemia  monocytic  acute  MLAA-34  heat-shock protein 70
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号